At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,380 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
Children's Hospital Medical Center, Cincinnati·observational·Posted Jan 10, 2008·Updated Aug 25, 2009
In Brief
An observational study for Neuroblastoma and Pheochromocytoma. Completed, enrolled 1,380 participants.
Detailed Summary
I-123-MIBG is used to image patients with neuroblastoma, pheochromocytoma and other neural crest tumors
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNeuroblastoma, Pheochromocytoma
Countries--
CollaboratorsUniversity of Cincinnati
Timeline
N/ACompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 1991
First PostedJan 2008
Primary CompletionDec 2008
TodayJul 2026
First PostedJan 10, 2008
Enrollment StartJan 1, 1991
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 17.9 yearsPosted 18.5 years ago